Nevertheless, combination of anti‐PD‐1 antibody with BRAFi or anti‐mVEGFA induced a significant reduction in tumor growth as compared to single BRAFi or anti‐mVEGFA alone (Fig. 4C, right top panel and left bottom panel). The gene discussed is PDCD1; the disease is neoplasm.